FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| ALVOCELL | Heartseed Inc. | Artcomplex Center 302, 12-9, Daikyo-cho, Shinjuku-ku Tokyo 160-0015 Japan | Cells for medical use; living cells for medical use;Cells differentiated from stem cells and stem cells for scientific and medical research purposes or for laboratory use other than for medical or veterinary use; other cells other than for medical or veterinary use; |
| ASTROSTEM | OSIRIS THERAPEUTICS, INC. | 7015 Albert Einstein Drive Columbia MD 21046 | Cells for medical use, namely, for the treatment of neural injury and deficit; |
| DECOMED BIOLOGICAL IDENTITY | Deco Med Srl | VIA DELLE INDUSTRIE 2 I-30020 MARCON (VE) Italy | Cells for medical use; stem cells; living cells for medical use; biological implants; surgical implants comprised of living tissues; surgical implants grown from stem cells [living tissues]; implants comprising living tissue; surgical implants grown from stem cells; implants for guided tissue regeneration; arterial grafts; skin grafts; transplants [living tissues]; implantable textile material to encourage the growth of tissue; implantable materials for use in guided tissue regeneration; bone void fillers consisting of natural materials; bone void fillers comprised of living tissues; scapulars for surgical purposes; processed human donor skin for the replacement of soft tissue; bone fillers consisting of living materials; biological tissue for implantation; human allograft tissue;Fitting of prosthetic devices; fitting of prosthetics; fitting of artificial limbs, prosthetic devices and prostheses; medical services; medical treatment services; medical analysis for the diagnosis and treatment of persons; medical clinic services; advisory services relating to medical services; medical counseling; human healthcare services;Biodegradable prostheses; implanted prosthesis; artificial limbs; medical devices for closing wounds; prosthetics and artificial implants;Design of prostheses; design and development of prostheses; development of prostheses; scientific research and development; research and development of vaccines and medicines; pharmaceutical research and development; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; consultancy relating to research and development in the field of therapeutics; consultancy relating to pharmaceutical research and development; research and development services in the field of antibody technology; provision of information and data relating to medical and veterinary research and development; medical and pharmacological research services; |
| ETIL | KSQ Therapeutics, Inc. | 4 Maguire Road Lexington MA 02421 | Cells for medical use; |
| F-HISIEC | FUJIFILM CORPORATION | 26-30, Nishiazabu 2-chome Minato-ku, Tokyo 106-8620 Japan | Cells for medical use; cell preparations for the treatment of diseases or disorders, namely gastrointestinal diseases and disorders, toxicity, intestinal inflammation, intestinal wounds, fibrosis, and gastrointestinal tract infections; intestinal epithelial cells for medical purposes; intestinal epithelial cell preparations for the treatment of gastrointestinal diseases; pharmaceutical preparations to evaluate the toxicity, metabolism, drug absorption and compound efficacy of the small intestines; medicinal preparations to evaluate the toxicity, metabolism, drug absorption and compound efficacy of the small intestines;Cells for scientific or research purposes, other than for medical or veterinary purposes; cell-derived preparations for scientific or research purposes; intestinal epithelial cells from human Induced Pluripotent Stem cells, used for scientific or research purposes for drug development; cellular tissue models, namely, biological tissue cultures containing human Induced Pluripotent Stem cells for measuring intestinal absorption efficiency, used for scientific or research purposes for drug development; cells, tissue models in the nature of biological tissue cultures, cell growth media, and biomaterials, all for use in biological, biomedical, and life sciences research; |
|
|
|||
| FLASH-CAR | Avalon Globocare Corp. | 4400 Route 9 South, Suite 3100 Freehold NJ 07728 | Cells for medical use in the nature of cells generated by ribonucleic acid (RNA) based on chimeric antigen receptor (CAR) modification of immune effector cells;Cells for research in the nature of cells generated by ribonucleic acid (RNA) based on chimeric antigen receptor (CAR) modification of immune effector cells; |
| GLYCOSTEM | Glycostem Therapeutics B.V. | Kloosterstraat 9 Oss 5349AB Netherlands | Cells for medical use;GLYCO STEM;Business and administrative services, namely, business administration services, business consultancy; compilation of statistics relating to the conduct of clinical and medical studies, surveys; collection and management of medical data in a database in the field of medical research; information, consultancy and advice on the aforementioned services, whether or not via the internet;Medical services; cultivation of cells for medical use; information, consultancy and advice on the above services, whether or not via the internet;Scientific and technological services, namely, scientific research, analysis, testing in the field of cellular immunotherapy; medical research services, including clinical studies, blood analysis services, health research and stem cell research services; industrial analysis and research services in the field of cells for medical use; hosting of databases featuring information about discussions in the field of scientific research; preparing, conducting and providing of scientific studies and research in the field of cellular immunotherapy for medical purposes; clinical research and bioscience studies for industrial purposes in the field of cellular immunotherapy; preparation of reports in the nature of scientific studies and research in the field of cellular immunotherapy for medical purposes; medical laboratory services, bacteriology laboratories, or chemical laboratories; creation of control programs for automation in the field of medical and industrial research, namely, for automated measurement, assembly, adjustment, and related visualization; clinical research services in the field of cellular immunotherapy; information, advice and consultancy relating to the aforesaid services, whether or not via the internet; |
| H2STEM | Promethera Therapeutics, Société anonyme | Rue Granbonpré 11 B-1435 Mont-Saint-Guibert Belgium | Cells for medical use, namely, stem cells for medical purposes, progenitor cells for medical purposes;H TWO STEM; |
| IPS ACADEMIA JAPAN | iPS Academia Japan, Inc. | 207 International Science Innovation Japan | Cells for medical use; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides;Collection, analysis, evaluation and provision of information relating to intellectual property rights; arranging of agreements for intellectual property rights; licensing of intellectual property rights; advisory and consultancy services relating to intellectual property rights; conducting prior researches relating to intellectual property rights; |
| LSII | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries;LIFE SCIENCE INSTITUTE INC; |
| LURITECY | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording LURITECY has no meaning in a foreign language.; |
| LYFMUZE | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording LYFMUZE has no meaning in a foreign language.; |
| MARCHYMEL | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording MARCHYMEL has no meaning in a foreign language.; |
| MUAFEY | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording MUAFEY has no meaning in a foreign language.; |
| MUAFFY | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells; pharmaceutical preparations containing stem cells; pharmaceutical composition containing cells; pharmaceutical composition containing stem cells; |
| NEURARREST | Cell Cure Neurosciences Ltd. | 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 | cells for medical use, namely, living cells for use in the treatment of neurodegenerative diseases;NEUROSCIENCES ARREST; NEURODEGENERATIVE ARREST; |
| NYFOLMO | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording NYFOLMO has no meaning in a foreign language.; |
| OPREGEN | Cell Cure Neurosciences Ltd. | 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 | Cells for medical use, namely, living cells intended for use in the treatment of retinal degenerative disease;The wording OPREGEN has no meaning in a foreign language.; |
| OPREVITA | Cell Cure Neurosciences Ltd. | 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 | Cells for medical use, namely, living cells intended for use in the treatment of retinal degenerative diseases; |
| OSIRIS | OSIRIS THERAPEUTICS, INC. | 7015 Albert Einstein Drive Columbia MD 21046 | Cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon;Research and development for pharmaceutical products, namely, screening and genetic engineering of cell therapy products; |
| RHEOBRICK | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Plesmanlaan 121 NL-1066 CX Amsterdam Netherlands | Cells for medical use; small molecule titratable switches for medical use;RHEO BRICK;Medical treatment involving small molecule titratable switches; cell therapy;Platform as a service (PaaS) for technologies based on small molecule titratable switches for cell therapies; research and development in the field of molecules, switches and cells; |
| SLEEK | EDITAS MEDICINE, INC. | 11 Hurley Street Cambridge MA 02141 | Cells for medical use; cell components for medical use, namely, protein RNA complexes for medical use; cell components for medical use, namely, DNA and RNA for medical use; cell components for medical use, namely, DNA and RNA vectors for medical use; cell components for medical use, namely, DNA and RNA plasmids for medical use;Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use; |
| SQZ AAC | SQZ Biotechnologies Company | 200 Arsenal Yards Blvd., Suite 210 Watertown MA 02472 | Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of cancer or infectious diseases; kit containing cells for medical use, namely, cells for use in creating cell therapies encapsulating peptide and protein antigens and other immune stimulating compounds for the treatment of cancer or infectious diseases;Cell-based therapy services for the treatment of cancer or infectious diseases featuring cells encapsulating peptide and protein antigens; |
| SQZ ACTIVATING ANTIGEN CARRIERS | SQZ Biotechnologies Company | 200 Arsenal Yards Blvd., Suite 210 Watertown MA 02472 | Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of cancer or infectious diseases; kit containing cells for medical use, namely, cells for use in creating cell therapies encapsulating peptide and protein antigens and other immune stimulating compounds for the treatment of cancer or infectious diseases;Cell-based therapy services for the treatment of cancer or infectious diseases featuring cells encapsulating peptide and protein antigens;ACTIVATING ANTIGEN CARRIERS; |
| SQZ ANTIGEN CARRIERS | SQZ Biotechnologies Company | 200 Arsenal Yards Blvd., Suite 210 Watertown MA 02472 | Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for general medical conditions for medical purposes;Cell-based therapy services for the treatment of general medical conditions featuring cells encapsulating peptide and protein antigens for medical purposes;ANTIGEN CARRIERS; |
| SQZ TOLERIZING ANTIGEN CARRIERS | SQZ Biotechnologies Company | 200 Arsenal Yards Blvd., Suite 210 Watertown MA 02472 | Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of auto-immune or aberrant immune activation disorders for medical purposes;Cell-based therapy services for the treatment of auto-immune or aberrant immune activation disorders featuring cells encapsulating peptide and protein antigens for medical purposes;TOLERIZING ANTIGEN CARRIERS; |
| SQZ-AC | SQZ Biotechnologies Company | 200 Arsenal Yards Blvd., Suite 210 Watertown MA 02472 | Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for general medical conditions for medical purposes;Cell-based therapy services for the treatment of general medical conditions featuring cells encapsulating peptide and protein antigens for medical purposes; |
| SQZ-TAC | SQZ Biotechnologies Company | 200 Arsenal Yards Blvd., Suite 210 Watertown MA 02472 | Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of auto-immune or aberrant immune activation disorders for medical purposes;Cell-based therapy services for the treatment of auto-immune or aberrant immune activation disorders featuring cells encapsulating peptide and protein antigens for medical purposes; |
| SSEACHYM | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording SSEACHYM has no meaning in a foreign language.; |
| SSEAMCYTE | LIFE SCIENCE INSTITUTE, INC. | 1-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8251 Japan | Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries;The wording SSEAMCYTE has no meaning in a foreign language.; |
| SYNFINGER | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Plesmanlaan 121 NL-1066 CX Amsterdam Netherlands | Cells for medical use; small molecule titratable switches for medical use;Medical treatment involving small molecule titratable switches; cell therapy;Platform as as service (PaaS) for technologies based on small molecule titratable switches for cell therapies; research and development in the field of molecules, switches and cells; |
| TFINITY | Fate Therapeutics, Inc. | Suite 200 3535 General Atomics Court San Diego CA 92121 | Cells for medical use; therapeutic cell preparation for the treatment of cancer, infectious diseases, and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies; pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders; kits comprised of cells and pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders for medical or clinical use; bio-engineered component for a therapeutic material, namely, cell lines for medical or clinical use used for immunotherapy; |
| TFINITY | Fate Therapeutics, Inc. | Suite 200 3535 General Atomics Court San Diego CA 92121 | Cells for medical use; therapeutic cell preparation for the treatment of cancer, infectious diseases, and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies; pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders; kits comprised of cells and pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders for medical or clinical use; bio-engineered component for a therapeutic material, namely, cell lines for medical or clinical use used for immunotherapy; |
Where the owner name is not linked, that owner no longer owns the brand |
|||